Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 7297
TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50: 11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50: 11nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187258(US9169234, 23)
Affinity DataIC50: 12nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187257(US9169234, 22)
Affinity DataIC50: 19nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50: 64nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187260(US9169234, 32)
Affinity DataIC50: 69nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50: 84nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187256(US9169234, 21)
Affinity DataIC50: 86nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50: 310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187259(US9169234, 24)
Affinity DataIC50: 310nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50: 330nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50: 340nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187251(US9169234, 2)
Affinity DataIC50: 360nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187250(US9169234, 1)
Affinity DataIC50: 400nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50: 1.00E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187255(US9169234, 18)
Affinity DataIC50: 1.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187261(US9169234, 12)
Affinity DataIC50: 2.10E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50: 2.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50: 2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187252(US9169234, 3)
Affinity DataIC50: 2.80E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50: 3.20E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187253(US9169234, 16)
Affinity DataIC50: 3.40E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent

TargetSepiapterin reductase(Human)
Solace Pharmaceuticals

US Patent
LigandPNGBDBM187254(US9169234, 17)
Affinity DataIC50: 4.50E+3nMpH: 6.5 T: 2°CAssay Description:To screen for SPR inhibition, a biochemical assay based on LC/MS (and chromogenic) read-out has been developed. The LC/MS assay monitors the product ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2016
Entry Details
Go to US Patent